Medline Inc.
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Trading Plan Arrangements
The table below summarizes the terms of any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement” (each as defined in Item 408 of Regulation S-K of the Exchange Act)adopted orterminated by our officers or directors during the three months ended September 26, 2026. The trading arrangement listed below was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
| Name | Title | Date of Adoption or Termination | Duration of Trading Arrangement | Number of Shares to be Sold Pursuant to the Trading Arrangement |
|---|---|---|---|---|
| Stephen L. Miller | Former Chief Operating Officer | Terminated his previously disclosed plan on August 13, 2026 | The terminated plan was scheduled to expire December 31, 2026 | The terminated plan covered up to 100% of the shares of Class A common stock issued upon the vesting and exchange of 808,451 Incentive Units |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.